Drugs / Leucovorin/levofolinate calcium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06997497 Background | Jul 2025 → Mar 2029 expected | colon adenocarcinoma, rectum adenocarcinoma | Merck Sharp & Dohme LLC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leucovorin/levofolinate calcium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06997497 ↗ |